U.S. Polymerase Chain Reaction Market – Industry Trends and Forecast to 2030

U.S. Polymerase Chain Reaction Market Analysis and Size

The U.S. polymerase chain reaction market is expected to grow in the forecast year due to the rise in the number of market players and the availability of advanced technological diagnostic devices. The increasing development in the field of advanced techniques is further expected to boost market growth. However, difficulties such as the stringent regulations for the production and commercialization of treatment drugs and medical devices for diagnosis and surgery are expected to restrain market growth in the forecast period.

Data Bridge Market Research analyzes that, U.S. polymerase chain reaction market is expected to reach the value of USD 11,168.47 million by 2030, at a CAGR of 12.2% during the forecast period. This market report also covers pricing analysis and technological advancements in depth.

Market Definition

Polymerase Chain Reaction (PCR) is a method widely used to make millions to billions of copies of a specific DNA sample rapidly, allowing scientists to amplify a very small sample of DNA or a part of it sufficiently to enable detailed study. It is a technique used to make numerous copies of a specific segment of DNA quickly and accurately. PCR is based on using the ability of DNA polymerase to synthesize new strands of DNA complementary to the offered template strand. The majority of PCR methods rely on thermal cycling. Thermal cycling exposes reactants to repeated cycles of heating and cooling to permit different temperature-dependent reactions—specifically, DNA melting and enzyme-driven DNA replication.

U.S. Polymerase Chain Reaction Market Dynamics

This section deals with understanding the market drivers, advantages, opportunities, restraints, and challenges. All of this is discussed in detail below:

DRIVERS

• Rise in the Availability of PCR Diagnostics

The polymerase chain reaction is one of the most widely used techniques in modern biology. PCR is based on a molecular technique for in-vitro amplification which generate millions number of copies of a specific region in a DNA strand. The rise in availability and the adoption of PCR devices is due to the diagnosis of various diseases and rapid results. PCR is a simple and widely used process in which minute amounts of DNA can be amplified into multiple copies. In addition to the rapidity with which this assay works, it can quantitatively demonstrate how much of a particular sequence is present.

For instance,

• In August 2020, as per the national human genome research institute, the rise in the availability of PCR is due to a fast and inexpensive technique used to amplify small segments of DNA. The technology availability is rising as it is rapid, accurate, and scalable making it ideal for large-scale viral testing

Thus, increasing the production of PCR instruments and reagents also enhances the efficiency of product availability, for this reason, a rise in the availability of PCR diagnostics is expected to drive the growth of the market.

• Increasing Application of PCR

PCR has many research and practical applications. PCR has been routinely used in DNA cloning, medical diagnostics, and forensic analysis of DNA. The PCR technique has become a standard diagnostic and research tool in the field of dentistry. PCR and other molecular biology techniques enable the diagnosis of infectious microbes that cause maxillofacial infections. This helps in the effective management of conditions such as periodontal disease, caries, oral cancer, and endodontic infections.

For instance,

• In May 2023, as per NCBI Article, PCR is the most well-developed molecular technique up to now, and has a wide range of already fulfilled, and potential, clinical applications, including specific or broad-spectrum pathogen detection, evaluation of emerging novel infections, surveillance, early detection of biothreat agents

Thus, on concluding, the increasing applications of PCR is expected to drive the growth of the market.

OPPORTUNITY

• Government Initiatives to Implement Screening Programs for Various Diseases

The burden of diseases continues to increase globally and has great financial, emotional, and physical stress on health systems, families, and individuals. In countries where the healthcare system is strong, the survival rate in many types of diseases, such as cancer is improved due to quality care, increased awareness, and accessible early detection. According to Centers for Disease Control and Prevention, the U.S.-Pacific islands and territories through the National Comprehensive Cancer Control Program (NCCCP) adapted to form or support alliances to combat cancer in their communities which led to increase the awareness of lung cancer screening programs and use of PCR diagnosis for early detection as PCR allows pieces of DNA to be amplified find and diagnose a genetic condition or a disease related to cancer.

For instance,

• In March 2021, as per NCBI Article, the government directed that covid-19 screening program should be performed in healthcare workers as they are at a high risk of infection and they potentially experience more significant risks for emerging infectious diseases owing to occupational exposure to sick patients and virus-contaminated surfaces

The growing government initiatives to implement screening programs for various diseases is expected to act as opportunity for the growth of the market.

RESTRAINT / CHALLENGE

• Limitations while Analyzing the Novel Complex Device

Analyzing a complex medical device involves understanding the device’s context of use, workload, and the environment in which it will be used. There are various factors that contributes to the complexity of novel product used in laboratories. The continued engagement between staff and device manufacturers early in the development process is much needed and becomes mandatory to understand in order to operate the part or overall setup. The technological challenges for the PCR diagnosis in getting complex due to advances that consist of a heterogeneous set of novel and widely disparate technologies.

In recent years, there has been an increased use of AI/ML in medical devices, especially for tasks that require the analysis of large volumes of data or the interpretation of complex information.The limitations in the detection and analysis of novel complex products such as machines, tools and equipment’s are hampering the growth of the U.S. polymerase chain reaction market.

Recent Developments

• In February 2022, Thermo Fisher Scientific Inc. announced the launch of a new rapid environmental test to help in the fight against COVID-19. The Thermo Scientific Renvo Rapid PCR Test is the latest solution in the company’s in-air pathogen surveillance product portfolio. The Renvo Rapid PCR Test is performed on air samples collected using the company’s Thermo Scientific AerosolSense Sampler. This helped the organization in developing more revenue
• In March 2020, Bio-Rad Laboratories, Inc. announced that its Real-Time qPCR products are being used by testing laboratories globally to screen for COVID-19. This helped the organization in developing overall revenue

U.S. Polymerase Chain Reaction Market  Scope

The U.S. polymerase chain reaction market is segmented into five notable segments based on product type, method, application, end-user, and distribution channel. The growth amongst these segments will help you analyze meager growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Product Type

• Reagents
•  Instruments
•  Consumables
•  Software And Services

On the basis of product type, the market is segmented into reagents, instruments,  consumables, software, and services.

Method

• Real-Time PCR
•  Reverse-Transcriptase (RT) PCR
•  Conventional PCR
•  Multiplex PCR
•  Nested PCR
•  Hot Start PCR
•  Long-Range PCR
•  Assembly PCR
•  Inverse PCR
•  Others

On the basis of method, the market is segmented into real-time PCR, reverse-transcriptase (RT) PCR, conventional PCR, multiplex PCR, nested PCR, hot start PCR, long-range PCR, assembly PCR, inverse PCR, and others.

By Application

• Clinical
•  Life Science and Related Researches
•  Forensic Science
•  Environmental Microbiology
•  Other

On the basis of application, the market is segmented into clinical, life science and related researches, forensic science, environmental microbiology, and other.

By End Users

• Pharmaceutical and Biotechnology Companies
•  Hospitals and Clinics
•  Diagnostic Laboratories
•  Academic and Research Organizations
•  Forensic Laboratories
•  Reference Laboratories
•  Others

On the basis of end-user, the market is segmented into pharmaceutical and biotechnology companies, hospitals and clinics, diagnostic laboratories, academic and research organizations, forensic laboratories, reference laboratories, and others.

By Distribution Channel

• Direct Tender
•  Retail Sales
•  Others 

On the basis of distribution channel, the market is segmented into direct tender, retail sales, and others.

Competitive Landscape and U.S. Polymerase Chain Reaction Market Share Analysis

The U.S. polymerase chain reaction market competitive landscape provides details of the competitor. Details included are company overview, company financials, revenue generated, market potential, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, and application dominance. The above data points provided are only related to the companies' focus related to the market.

Some of the major market players operating in the U.S. polymerase chain reaction market  are Beckman Coulter, Inc, F. Hoffmann-La Roche Ltd, Promega Corporation, Illumina, Inc, Bio-Rad Laboratories, Inc, QIAGEN, Merck KGaA, GenScript, Thermo Fisher Scientific Inc, PerkinElmer Inc, Enzo Life Sciences, Inc., bioMérieux Inc, Takara Bio Inc., LGC biosearch technologies, Meridian bioscience, Inc., luminex corporation, and Agilent Technologies, Inc among others

SKU-70197